Non-Small Cell Lung Carcinoma Spheroid Models in Agarose Microwells for Drug Response Studies

    January 2022 in “ Lab on a Chip
    Qiyue Luan, Jeffrey H. Becker, Celine Macaraniag, Malek G. Massad, Jian Zhou, Takeshi Shimamura, Ian Papautsky
    Studysummary This study demonstrates that a 3D-printed agarose microwell platform supports the growth of size-uniform, viable NSCLC cancer spheroids, and can effectively evaluate drug responses using limited tumor material from biopsies, particularly with EGFR tyrosine kinase inhibitors gefitinib and osimertinib.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results